PUBLISHER: Future Markets, Inc. | PRODUCT CODE: 2114189
PUBLISHER: Future Markets, Inc. | PRODUCT CODE: 2114189
Industrial biomanufacturing uses living systems - microbes, mammalian, plant and insect cells, and increasingly cell-free enzymatic platforms - to produce molecules that would otherwise be made from petrochemical feedstocks or extracted from natural sources. It spans six commercial domains: biopharmaceuticals, industrial enzymes, biofuels, bioplastics, biochemicals and bio-agritech. The sector's economic case rests on three arguments rather than one. The first is decarbonisation: biological routes displace fossil feedstocks across chemicals, fuels, materials and food ingredients, and where carbon pricing tightens the cost gap narrows structurally rather than cyclically. The second is supply-chain resilience, since fermentation can be sited close to demand and run on local or waste-derived carbon. This has become explicit policy: the United States enacted the BIOSECURE Act in December 2025 and its National Security Commission on Emerging Biotechnology has identified limited domestic scale-up capacity as a structural weakness, while China has published target product lists to direct investment. The third is value capture - biomanufacturing creates new industrial ecosystems in strain design, bioprocess engineering and downstream separation rather than merely substituting inputs.
Biopharmaceuticals remain the largest value pool, with an addressable market approaching $1 trillion by 2030 across monoclonal antibodies, vaccines, recombinant proteins and the faster-growing cell, gene and RNA therapeutic segments. Industrial enzymes represent a mature multi-billion dollar market. Biofuels are the largest volume segment, and bioplastics, biochemicals and bio-agritech expanding from smaller bases. The technology frontier is moving on several fronts simultaneously: AI-driven protein and pathway design compressing design-build-test cycles; continuous and intensified fermentation displacing batch operation; cell-free systems removing the constraints of cell viability; and alternative feedstocks - C1 gases, lignocellulosics and captured CO₂ - reducing dependence on food crops.
The sector's record also warrants caution. Between 2019 and 2026 POET halted cellulosic production at Project Liberty, Clariant closed its Podari plant and exited biofuels, Fulcrum BioEnergy and Red Rock Biofuels entered bankruptcy without completing commercial production, both Enerkem sites failed, and Viridos filed for Chapter 11 after ExxonMobil ended a $350 million algae programme. No commercial biomass gasification-Fischer-Tropsch plant operates anywhere. Announced capacity consistently exceeds realised capacity, and forecasts should be read as contingent on a scale-up that has repeatedly proven harder than projected.
The Global Industrial Biomanufacturing Market 2027-2037 provides a comprehensive assessment of industrial biomanufacturing across its six commercial domains, combining technology analysis, market forecasts to 2037 and profiles of more than 1,000 companies. Industrial biomanufacturing has moved from a substitution play to a matter of industrial strategy, driven by decarbonisation targets, supply-chain security concerns and the emergence of AI-enabled biological design. This report examines what is genuinely commercial, what remains pre-commercial, and where announced capacity has failed to materialise. Coverage begins with production platforms - microbial fermentation, mammalian, plant and insect cell culture, transgenic systems and cell-free biomanufacturing - before addressing enabling technologies including synthetic biology, CRISPR-based strain engineering, continuous and intensified processing, downstream separation, and AI and robotics in bioprocess design.
Six market chapters then assess biopharmaceuticals, industrial enzymes, biofuels, bioplastics, biochemicals and bio-agritech. Each covers technology and materials analysis, market drivers, regulations, value chain, technology readiness, addressable market size, risks and opportunities, and global revenue forecasts segmented by product type, application and region. The report includes revenue and volume forecasts to 2037, capacity and consumption series for renewable diesel, biodiesel, bio-jet fuel, bioethanol, biomethane and bio-LNG, and detailed assessments of feedstock availability including waste lipids, lignocellulosics, C1 and C2 gases, and captured CO₂. More than 1,080 companies are profiled with descriptions, country of operation and website.
Contents
Companies profiled include 3Bar Biologics, 3DBioFibR, 3M, 9Fiber, Inc., AbbVie, Absci Corp, Adaptive Symbiotic Technologies, ADBioplastics, Adjuvants Plus, Adriano di Marti/Desserto, Aduro Clean Technologies, Inc., Advanced Biochemical (Thailand) Co., Ltd., Aemetis, Inc., AEP Polymers, Aeropowder Limited, AFINGEN®, Afyren, AGAE Technologies LLC, Again Bio, AgBiome, Agilyx, Agra Energy, Agragene, AGRANA Staerke GmbH, Agrinos, Agrivida, Agrobiomics, AgroRenew, AgroSpheres, Ahlstrom-Munksjo Oyj, AI Proteins, Air Company, Aircela Inc, Alexion Pharmaceuticals, Algaeing, Algal Bio Co., Ltd., Algenesis Corporation, Algenie, Algenl, Algenol, Alginor ASA, Algix LLC, Allied Carbon Solutions, Allozymes, Alnylam Pharmaceuticals, Alpha Biofuels (Singapore) Pte Ltd, Alto Neuroscience, AM Green, Amano Enzyme Inc., Amatera, Amfora, Amgen, AmicaTerra, Aminoverse, Amphista Therapeutics, AmphiStar, Amply Discovery, AMSilk GmbH, An Phat Bioplastics, Ananas Anam Ltd., Andermatt Biocontrol, Andritz AG, Anellotech, Inc., Ankor Bioplastics Co., Ltd., Anodyne Chemistries, ANPOLY, Inc., Anqing He Xing Chemical Co., Ltd., Ansa Biotechnologies, Antheia, APChemi Pvt. Ltd., Apeiron Bioenergy, Aperam BioEnergia, Apexzymes, Aphea.Bio, Applied Bioplastics, Applied Research Associates, Inc. (ARA), Aqemia, Aquafil S.p.A., Aquapak Polymers Ltd, Arcadia Biosciences, Arcadia eFuels, Archer Daniel Midland Company (ADM), Arctic Biomaterials Oy, Ardra Bio, Arekapak GmbH, Arkema S.A, Arlanxeo, Arrow Greentech, Arysta LifeScience, Arzeda, Arzeda Corp., Asahi Kasei Chemicals Corporation, ASB Biodiesel Limited, Ascribe Bioscience, AstraZeneca, Atantares, Athos Therapeutics, Atlantica Agricola, Atmonia, Atomwise, Attis Innovations, llc, Aurigene Pharmaceutical Services, AVA Biochem AG, Avalon BioEnergy, Avani Eco, Avantium B.V., Avicenna Biosciences, Avient Corporation, Avioxx, Axcelon Biopolymers Corporation, Ayas Renewables Inc., Azolla, Azotic Technologies, B-PREG, Balrampur Chini Mills, Bambooder Biobased Fibers B.V., Basecamp Research, BASF, BASF SE, Bast Fiber Technologies, Inc., Bayer CropScience, BBCA Biochemical & GALACTIC Lactic Acid Co., Ltd., Bcomp ltd., BDI-BioEnergy International GmbH, BEE Biofuel, Bee Vectoring Technologies, BeiGene, Benefuel Inc., BenevolentAI, Better Fibre Technologies, Betulium Oy, Beyond Leather Materials ApS, BigHat Biosciences, BigSis, Bio Fab NZ, BIO-FED, BIO-LUTIONS International AG, Bio-Oils, Bio2Materials Sp. z o.o., Bio2Oil ApS, BioAge Labs, Biobest, BioBetter, Biocatalysts Ltd., Bioceres Crop Solutions, Biocon, BioConsortia, BIOD Energy, BioEnz Technologies, Bioextrax AB, Biofiber Tech Sweden AB, Biofibre GmbH, Biofine Technology, LLC, Bioform Technologies, Biofy, BiogasClean A/S, Biogen, Biojet AS, Biokemik, Bioleather, Biolevel, Biolexis Therapeutics, Bioline AgroSciences, BIOLO, BioLogiQ, Inc., BioMap, Biomass Resin Holdings Co., Ltd., Biomatter, Biomatter Designs, Biome Bioplastics, Biome Makers, Bionema, BioNTech, BioPhero, Biophilica, BioPhy, Bioplastech Ltd, Bioplastix, Biopolax, Bioptimus SAS, BioSolutions, Biosyntia, Biotalys, BIOTEC GmbH & Co. KG, Biotecam, Biotechnology SL, Biotelliga, Biotensidion GmbH, Biotic Circular Technologies Ltd., Biotrem, Biotrop, Biovox, Bioweg, bitBiome, BlockTexx Pty Ltd., Bloom Biorenewables SA, BluCon Biotech GmbH, Blue BioFuels, Inc., Blue Ocean Closures, BlueAlp Technology, Bluepha Beijing Lanjing Microbiology Technology Co., Ltd., Bolt Threads, Bontera, Boreal Bioproducts, Borealis AG, Borregaard Chemcell, Bosk Bioproducts Inc., Botanical Solutions, Bowil Biotech Sp. z o.o., Braskem SA, Braven Environmental, LLC, Brightmark Energy, Brightseed, Bristol Myers Squibb, bse Methanol GmbH, BTG Bioliquids B.V., Bucha Bio, Inc., Burgo Group S.p.A., Buyo Bioplastic Ltd., Byogy Renewables, Inc., B’ZEOS, C-Zero Inc., C1 Green Chemicals AG, C16 Biosciences, Cambrium GmbH, Caphenia GmbH, CARAPAC Company, Carapace Biopolymers, Carbiolice, Carbios, Carbon Collect Limited, Carbon Crusher, Carbon Engineering Ltd., Carbon Infinity Limited, Carbon Recycling International, Carbon Sink LLC, Carbonade, CarbonBridge, Carbonwave, Carbyon BV, Cardia Bioplastics Ltd., Cardolite, Cargill, Cascade Biocatalysts, Cascade Biocatalysts, Inc., Cass Materials Pty Ltd, Cassandra Oil AB, Casterra Ag Ltd., Catalyxx, Cathay Industrial Biotech, Ltd., Celanese Corporation, Cellicon B.V., CellON, Celltrion, Cellucomp Ltd., Celluforce, Cellugy, Cellutech AB (Stora Enso), Celtic Renewables Ltd., Century Health Technology, Inc., Ceradis, Cereal Process Technologies (CPT), CERT Systems, Inc., Certis USA, CF Industries Holdings, Inc., CH-Bioforce Oy, ChainCraft, ChakraTech, Checkerspot, Inc., Chempolis Oy, Chestnut Bio Polymers, ChiralVision B.V., Chitelix, Chitose Bio Evolution Pte Ltd., Chongqing Bofei Biochemical Products Co., Ltd., Chuetsu Pulp & Paper Co., Ltd., Cibus, CIMV, CinderBio, Circa Group, Circla Nordic, Circular Systems, CJ Biomaterials, Inc., Clariant, Clariant AG, CleanJoule, Climeworks, CNF Biofuel AS, CO2BioClean, Coastgrass ApS, Codexis, COFCO Cooperation Ltd., Coffeeco Upcycle, Conagen, Concentric Agriculture, Concord Blue Engineering, Constructive Bio, Cool Planet Energy Systems, Corn Next, Corsair Group International, Corteva Agriscience, Corumat, Inc. and more....